Cargando…

Study protocol for a phase III randomised controlled trial of Sailuotong (SLT) for vascular dementia and Alzheimer’s disease with cerebrovascular disease

Vascular dementia (VaD) accounts for 15–20% of all dementia cases. It is a syndrome of acquired cognitive impairment with a complex pathophysiological basis. A novel herbal formulation (Sailuotong; SLT) consisting of Panax ginseng C.A Mey, Ginkgo biloba L and Crocus sativus L extracts was developed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karamacoska, Diana, Chan, Daniel K. Y., Leung, Isabella, Liu, Jian-xun, Brodaty, Henry, Fahey, Paul P., Bensoussan, Alan, Chang, Dennis H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2023
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10016672/ https://www.ncbi.nlm.nih.gov/pubmed/36920949 http://dx.doi.org/10.1371/journal.pone.0265285

Ejemplares similares

Endothelium-Independent Vasodilatory Effect of Sailuotong (SLT) on Rat Isolated Tail Artery
por: Yeon, S. Y., et al.
Publicado: (2020)

The effect of Sailuotong (SLT) on neurocognitive and cardiovascular function in healthy adults: a randomised, double-blind, placebo controlled crossover pilot trial
por: Steiner, Genevieve Z., et al.
Publicado: (2016)

Study protocol for a randomised, double-blind, placebo-controlled 12-week pilot phase II trial of Sailuotong (SLT) for cognitive function in older adults with mild cognitive impairment
por: Steiner, Genevieve Z., et al.
Publicado: (2018)

A pilot randomized controlled trial of WeiNaoKang (SaiLuoTong) in treating vascular dementia
por: Liu, Junguang, et al.
Publicado: (2022)

A randomized, double‐blind, placebo‐controlled, parallel‐group 12‐week pilot phase II trial of SaiLuoTong (SLT) for cognitive function in older adults with mild cognitive impairment
por: Steiner‐Lim, Genevieve Z., et al.
Publicado: (2023)

Efficacy and safety of the compound Chinese medicine SaiLuoTong in vascular dementia: A randomized clinical trial
por: Jia, Jianping, et al.
Publicado: (2018)

Sailuotong Prevents Hydrogen Peroxide (H(2)O(2))-Induced Injury in EA.hy926 Cells
por: Seto, Sai Wang, et al.
Publicado: (2017)

Sailuotong Capsule Prevents the Cerebral Ischaemia-Induced Neuroinflammation and Impairment of Recognition Memory through Inhibition of LCN2 Expression
por: Zhang, Yehao, et al.
Publicado: (2019)

Alzheimer’s disease, cerebrovascular disease and dementia: lump, split or integrate?
por: Biessels, Geert Jan
Publicado: (2022)

Cerebrovascular disease in ageing and Alzheimer’s disease
por: Love, Seth, et al.
Publicado: (2015)

Associations of cerebrovascular metabolism genotypes with neuropsychiatric symptoms and age at onset of Alzheimer’s disease dementia
por: de Oliveira, Fabricio F., et al.
Publicado: (2017)

Efficacy study of galantamine in possible Alzheimer's disease with or without cerebrovascular disease and vascular dementia in Thai patients: a slow-titration regimen
por: Thavichachart, N, et al.
Publicado: (2006)

Vascular and Alzheimer Disease in Dementia
por: Strandberg, Timo E., et al.
Publicado: (2020)

The cerebral circulation and cerebrovascular disease III: Stroke
por: Chandra, Ankush, et al.
Publicado: (2017)

Chinese Herbal Preparation SaiLuoTong Alleviates Brain Ischemia via Nrf2 Antioxidation Pathway–Dependent Cerebral Microvascular Protection
por: Fan, Xiao-Di, et al.
Publicado: (2021)

Cerebrovascular disease promotes tau pathology in Alzheimer’s disease
por: Laing, Krystal K, et al.
Publicado: (2020)

The occurrence of cerebrovascular atherosclerosis in Alzheimer’s disease patients
por: Yuan, Jing, et al.
Publicado: (2013)

Cerebrovascular pathology in Down syndrome and Alzheimer disease
por: Head, Elizabeth, et al.
Publicado: (2017)

Cerebrovascular insulin receptors are defective in Alzheimer’s disease
por: Leclerc, Manon, et al.
Publicado: (2022)

The PD COMM trial: a protocol for the process evaluation of a randomised trial assessing the effectiveness of two types of SLT for people with Parkinson’s disease
por: Masterson-Algar, Patricia, et al.
Publicado: (2017)

Does tai chi improve psychological well-being and quality of life in patients with cardiovascular disease and/or cardiovascular risk factors? A systematic review
por: Yang, Guoyan, et al.
Publicado: (2022)

Serum Uric Acid Concentration in Patients with Cerebrovascular Disease (Ischemic Stroke and Vascular Dementia)
por: Serdarevic, Nafija, et al.
Publicado: (2020)

Lipids at the Nexus between Cerebrovascular Disease and Vascular Dementia: The Impact of HDL-Cholesterol and Ceramides
por: Sergi, Domenico, et al.
Publicado: (2023)

Long-Term Outcomes of Selective Laser Trabeculoplasty (SLT) Treatment
por: Ayala, Marcelo, et al.
Publicado: (2011)

Predictive factors of success in selective laser trabeculoplasty (SLT) treatment
por: Ayala, Marcelo, et al.
Publicado: (2011)

Baseline Factors Predictive of SLT Response: A Prospective Study
por: Bruen, Robin, et al.
Publicado: (2012)

Substrates of the MAPK Slt2: Shaping Yeast Cell Integrity
por: González-Rubio, Gema, et al.
Publicado: (2022)

Hsp90 and phosphorylation of the Slt2(Mpk1) MAP kinase activation loop are essential for catalytic, but not non-catalytic, Slt2-mediated transcription in yeast
por: Millson, Stefan H., et al.
Publicado: (2022)

Dysfunction of Cerebrovascular Endothelial Cells: Prelude to Vascular Dementia
por: Wang, Feixue, et al.
Publicado: (2018)

Imaging of cerebrovascular pathology in animal models of Alzheimer's disease
por: Klohs, Jan, et al.
Publicado: (2014)

Traumatic Brain Injury and Alzheimer's Disease: The Cerebrovascular Link
por: Ramos-Cejudo, Jaime, et al.
Publicado: (2018)

APOE and Alzheimer’s Disease: Neuroimaging of Metabolic and Cerebrovascular Dysfunction
por: Brandon, Jason A., et al.
Publicado: (2018)

Cerebrovascular Senescence Is Associated With Tau Pathology in Alzheimer's Disease
por: Bryant, Annie G., et al.
Publicado: (2020)

Systemic infection exacerbates cerebrovascular dysfunction in Alzheimer’s disease
por: Asby, Daniel, et al.
Publicado: (2021)

A new dawn of preventing dementia by preventing cerebrovascular diseases
por: Pan, Yuesong, et al.
Publicado: (2020)

The Closing-in Phenomenon in Alzheimer's Disease and Vascular Dementia
por: Chin, Juhee, et al.
Publicado: (2005)

Occludin is overexpressed in Alzheimer's disease and vascular dementia
por: Romanitan, Mihaela Oana, et al.
Publicado: (2007)

Alzheimer and vascular brain disease: Senile dementia
por: Engelhardt, Eliasz, et al.
Publicado: (2015)

Influence of cerebrovascular disease on brain networks in prodromal and clinical Alzheimer’s disease
por: Chong, Joanna Su Xian, et al.
Publicado: (2017)

IOP Maintenance in SLT-treated Eyes following Subsequent Phacoemulsification and IOL
por: Ansari, Ejaz
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_vk5ef9ri1nbji4qe8r09l4o81b